|  Help  |  About  |  Contact Us

Publication : ARS2 is required for retinal progenitor cell S-phase progression and Müller glial cell fate specification.

First Author  O'Sullivan C Year  2020
Journal  Biochem Cell Biol Volume  98
Issue  1 Pages  50-60
PubMed ID  30673303 Mgi Jnum  J:309398
Mgi Id  MGI:6757532 Doi  10.1139/bcb-2018-0250
Citation  O'Sullivan C, et al. (2020) ARS2 is required for retinal progenitor cell S-phase progression and Muller glial cell fate specification. Biochem Cell Biol 98(1):50-60
abstractText  During a developmental period that extends postnatally in the mouse, proliferating multipotent retinal progenitor cells produce one of 7 major cell types (rod, cone, bipolar, horizontal, amacrine, ganglion, and Muller glial cells) as they exit the cell cycle in consecutive waves. Cell production in the retina is tightly regulated by intrinsic, extrinsic, spatial, and temporal cues, and is coupled to the timing of cell cycle exit. Arsenic-resistance protein 2 (ARS2, also known as SRRT) is a component of the nuclear cap-binding complex involved in RNA Polymerase II transcription, and is required for cell cycle progression. We show that postnatal retinal progenitor cells (RPCs) require ARS2 for proper progression through S phase, and ARS2 disruption leads to early exit from the cell cycle. Furthermore, we observe an increase in the proportion of cells expressing a rod photoreceptor marker, and a loss of Muller glia marker expression, indicating a role for ARS2 in regulating cell fate specification or differentiation. Knockdown of Flice Associated Huge protein (FLASH), which interacts with ARS2 and is required for cell cycle progression and 3'-end processing of replication-dependent histone transcripts, phenocopies ARS2 knockdown. These data implicate ARS2-FLASH-mediated histone mRNA processing in regulating RPC cell cycle kinetics and neuroglial cell fate specification during postnatal retinal development.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

5 Expression

Trail: Publication